Growth Metrics

NeuroPace (NPCE) Gross Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 63.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -324.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 311.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 56.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -164.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 124.00
10 NeuroPace 558.86 Mn 504.88 Mn 18.05 Mn 1,011.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,011.00
Dec 31, 2025 856.00
Sep 30, 2025 600.00
Jun 30, 2025 390.00
Mar 31, 2025 438.00
Dec 31, 2024 197.00
Sep 30, 2024 61.00
Jun 30, 2024 -70.00
Mar 31, 2024 -209.00
Dec 31, 2023 -124.00
Sep 30, 2023 -51.00
Jun 30, 2023 156.00
Mar 31, 2023 92.00